Great Lakes Advisors, LLC Biogen Inc. Transaction History

Great Lakes Advisors, LLC

  • $10.8 Billion
  • Q4 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$275.25 - $318.06 $3,303 - $3,816
12 Added 1.57%
777 $221,000
Q1 2023

May 10, 2023
SELL
$256.56 - $292.34 $18,728 - $21,340
-73 Reduced 8.71%
765 $212,000
Q4 2022

Feb 09, 2023
SELL
$252.44 - $306.72 $11,864 - $14,415
-47 Reduced 5.31%
838 $232,000
Q3 2022

Nov 09, 2022
SELL
$194.69 - $268.46 $87,221 - $120,270
-448 Reduced 33.61%
885 $236,000
Q2 2022

Aug 09, 2022
SELL
$187.54 - $223.02 $21.6 Million - $25.7 Million
-115,315 Reduced 98.86%
1,333 $272,000
Q1 2022

May 06, 2022
BUY
$193.77 - $244.14 $747,758 - $942,136
3,859 Added 3.42%
116,648 $24.6 Million
Q4 2021

Feb 09, 2022
BUY
$223.92 - $287.77 $5.63 Million - $7.24 Million
25,158 Added 28.71%
112,789 $27.1 Million
Q3 2021

Nov 09, 2021
BUY
$282.99 - $369.05 $998,954 - $1.3 Million
3,530 Added 4.2%
87,631 $24.8 Million
Q2 2021

Aug 11, 2021
SELL
$259.0 - $414.71 $3.81 Million - $6.1 Million
-14,706 Reduced 14.88%
84,101 $29.1 Million
Q1 2021

May 03, 2021
SELL
$242.95 - $284.63 $488,815 - $572,675
-2,012 Reduced 2.0%
98,807 $27.6 Million
Q4 2020

Feb 09, 2021
BUY
$236.26 - $355.63 $3.69 Million - $5.56 Million
15,634 Added 18.35%
100,819 $24.7 Million
Q3 2020

Nov 04, 2020
BUY
$264.77 - $305.71 $471,555 - $544,469
1,781 Added 2.14%
85,185 $24.2 Million
Q2 2020

Aug 07, 2020
SELL
$258.66 - $342.55 $8.42 Million - $11.2 Million
-32,553 Reduced 28.07%
83,404 $22.3 Million
Q1 2020

May 08, 2020
SELL
$268.85 - $341.04 $14.8 Million - $18.8 Million
-55,024 Reduced 32.18%
115,957 $36.7 Million
Q4 2019

Feb 07, 2020
SELL
$220.06 - $304.07 $12.3 Million - $17 Million
-55,893 Reduced 24.64%
170,981 $50.7 Million
Q3 2019

Nov 06, 2019
SELL
$217.44 - $243.88 $1.24 Million - $1.39 Million
-5,681 Reduced 2.44%
226,874 $52.8 Million
Q2 2019

Aug 05, 2019
SELL
$219.29 - $241.72 $247,139 - $272,418
-1,127 Reduced 0.48%
232,555 $54.4 Million
Q1 2019

May 07, 2019
BUY
$216.71 - $338.96 $18.6 Million - $29.1 Million
85,939 Added 58.17%
233,682 $55.2 Million
Q4 2018

Feb 13, 2019
SELL
$278.5 - $352.75 $438,637 - $555,581
-1,575 Reduced 1.05%
147,743 $44.5 Million
Q3 2018

Nov 30, 2018
SELL
$293.51 - $383.83 $4.9 Million - $6.41 Million
-16,698 Reduced 10.06%
149,318 $52.8 Million
Q2 2018

Aug 13, 2018
SELL
$257.52 - $306.91 $7.51 Million - $8.96 Million
-29,181 Reduced 14.95%
166,016 $48.2 Million
Q1 2018

May 07, 2018
BUY
$260.13 - $367.91 $32 Million - $45.2 Million
122,966 Added 170.24%
195,197 $47.5 Million
Q4 2017

Feb 08, 2018
BUY
$307.64 - $344.58 $21.4 Million - $23.9 Million
69,404 Added 2455.04%
72,231 $23 Million
Q3 2017

Nov 13, 2017
BUY
$281.15 - $329.69 $794,811 - $932,033
2,827
2,827 $885,000

Others Institutions Holding BIIB

# of Institutions
996
Shares Held
129M
Call Options Held
1.37M
Put Options Held
1.51M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $19.9B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email